Business Description
Lantheus Holdings Inc
NAICS : 325411
SIC : 2834
ISIN : US5165441032
Description
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.23 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.6 | |||||
| Debt-to-EBITDA | 0.98 | |||||
| Interest Coverage | 22.86 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.54 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.3 | |||||
| 3-Year EBITDA Growth Rate | 155.5 | |||||
| 3-Year FCF Growth Rate | 271.2 | |||||
| 3-Year Book Growth Rate | 15.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 24.45 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.44 | |||||
| 9-Day RSI | 44.53 | |||||
| 14-Day RSI | 49.06 | |||||
| 6-1 Month Momentum % | 64.94 | |||||
| 12-1 Month Momentum % | 69.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.68 | |||||
| Quick Ratio | 4.41 | |||||
| Cash Ratio | 2.88 | |||||
| Days Inventory | 44.69 | |||||
| Days Sales Outstanding | 76.63 | |||||
| Days Payable | 29.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | -1.78 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.5 | |||||
| Operating Margin % | 31.5 | |||||
| Net Margin % | 29.8 | |||||
| FCF Margin % | 25.51 | |||||
| ROE % | 53.04 | |||||
| ROA % | 25.87 | |||||
| ROIC % | 40.64 | |||||
| 3-Year ROIIC % | 634.43 | |||||
| ROC (Joel Greenblatt) % | 168.29 | |||||
| ROCE % | 39.5 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.01 | |||||
| Forward PE Ratio | 15.26 | |||||
| PE Ratio without NRI | 21.72 | |||||
| Shiller PE Ratio | 87.87 | |||||
| Price-to-Owner-Earnings | 21.14 | |||||
| PS Ratio | 5.37 | |||||
| PB Ratio | 7.43 | |||||
| Price-to-Tangible-Book | 9.61 | |||||
| Price-to-Free-Cash-Flow | 21.07 | |||||
| Price-to-Operating-Cash-Flow | 17.52 | |||||
| EV-to-EBIT | 12.99 | |||||
| EV-to-EBITDA | 11.76 | |||||
| EV-to-Revenue | 5.18 | |||||
| EV-to-Forward-Revenue | 4.1 | |||||
| EV-to-FCF | 20.32 | |||||
| Price-to-Projected-FCF | 2.76 | |||||
| Price-to-Graham-Number | 3.05 | |||||
| Price-to-Net-Current-Asset-Value | 23.98 | |||||
| Earnings Yield (Greenblatt) % | 7.7 | |||||
| FCF Yield % | 4.81 | |||||
| Forward Rate of Return (Yacktman) % | -33.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LNTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lantheus Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,438.011 | ||
| EPS (TTM) ($) | 6.1 | ||
| Beta | 0.11 | ||
| Volatility % | 52.7 | ||
| 14-Day RSI | 49.06 | ||
| 14-Day ATR ($) | 3.784256 | ||
| 20-Day SMA ($) | 110.5595 | ||
| 12-1 Month Momentum % | 69.89 | ||
| 52-Week Range ($) | 50.2 - 126.8899 | ||
| Shares Outstanding (Mil) | 69.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lantheus Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lantheus Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lantheus Holdings Inc Frequently Asked Questions
What is Lantheus Holdings Inc(LNTH)'s stock price today?
The current price of LNTH is $109.83. The 52 week high of LNTH is $126.89 and 52 week low is $50.20.
When is next earnings date of Lantheus Holdings Inc(LNTH)?
The next earnings date of Lantheus Holdings Inc(LNTH) is 2024-11-06.
Does Lantheus Holdings Inc(LNTH) pay dividends? If so, how much?
Lantheus Holdings Inc(LNTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers